Ionis Pharmaceuticals, Inc.
IONS
$75.83
$0.450.60%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -326.98M | -381.39M | -256.34M | -268.22M | -458.03M |
| Total Depreciation and Amortization | 24.74M | 22.69M | 20.62M | 21.61M | 21.74M |
| Total Amortization of Deferred Charges | 7.62M | 6.91M | 6.61M | 6.64M | 6.67M |
| Total Other Non-Cash Items | 124.16M | 134.42M | 118.55M | 148.90M | 132.89M |
| Change in Net Operating Assets | -740.16M | -51.22M | -136.46M | -139.50M | -205.05M |
| Cash from Operations | -910.63M | -268.58M | -247.01M | -230.57M | -501.78M |
| Capital Expenditure | -60.63M | -51.44M | -55.65M | -59.44M | -53.36M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 149.22M | -226.33M | 265.59M | -162.76M | 13.69M |
| Cash from Investing | 88.59M | -277.78M | 209.94M | -222.19M | -39.67M |
| Total Debt Issued | 770.00M | 770.00M | -- | -- | -- |
| Total Debt Repaid | -267.82M | -267.82M | -44.67M | -44.68M | -44.67M |
| Issuance of Common Stock | 247.67M | 192.60M | 85.22M | 500.05M | 501.36M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -18.95M | -18.95M | -- | -- | -- |
| Cash from Financing | 730.90M | 675.84M | 40.55M | 455.38M | 456.69M |
| Foreign Exchange rate Adjustments | 332.00K | 702.00K | 259.00K | 691.00K | 73.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -90.81M | 130.18M | 3.74M | 3.31M | -84.70M |